Jan 8 (Reuters) - Ventyx Biosciences Inc ( VTYX ):
* LILLY TO ACQUIRE VENTYX BIOSCIENCES TO ADVANCE ORAL
THERAPIES
TARGETING INFLAMMATORY-MEDIATED DISEASES
* VENTYX BIOSCIENCES INC - LILLY WILL ACQUIRE ALL OF
OUTSTANDING
SHARES OF VENTYX FOR $14.00 PER SHARE
* VENTYX BIOSCIENCES INC ( VTYX ) - PROPOSED DEAL FOR EQUITY VALUE OF
APPROXIMATELY $1.2 BILLION
* VENTYX BIOSCIENCES INC ( VTYX ) - TRANSACTION EXPECTED TO CLOSE IN
FIRST
HALF OF 2026
Source text:
Further company coverage: